Article
CREBBP knockdown enhances RAS/RAF/MEK/ERK signaling in Ras pathway mutated acute lymphoblastic leukemia but does not modulate chemotherapeutic response.
Haematologica - 1 Apr 2017
Dixon Zach A, Nicholson Lindsay, Zeppetzauer Martin, Matheson Elizabeth, Sinclair Paul, Harrison Christine J, Irving Julie A E
Abstract excerpt
Relapsed acute lymphoblastic leukemia is the most common cause of cancer-related mortality in young people and new therapeutic strategies are needed to improve outcome. Recent studies have shown that heterozygous inactivating mutations in the histone acetyl transferase, CREBBP, are particularly frequent in relapsed childhood acute lymphoblastic leukemia and associated with a hyperdiploid karyotype and KRAS...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
